Foreign invested firms turn down KPMA's recent demand to vow the observance of fair trade code

Published: 2002-06-10 07:00:00

Updated: 2002-06-10 07:00:00

Pharmaceutical industry sources say that there remains a serious disaccord between the Korea Pharmaceutical Manufacturers Association (KPMA) and foreign invested pharmaceutical firms, since the latter flatly rejected the KPMA's recent request to vow the observance of fair trade code, on the groun...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK